文献速递甲状腺疾病

脱细胞甲状腺基质构建生物工程化甲状腺的再生研究

Regeneration of a Bioengineered Thyroid Using Decellularized Thyroid Matrix.
PubMed 文献 · Thyroid · 2018-12-18

本研究采用1%十二烷基硫酸钠灌注离体大鼠甲状腺制备脱细胞支架,再以FRTL-5大鼠甲状腺细胞系经灌注接种重建甲状腺,并在体外形成三维滤泡结构、表达甲状腺球蛋白与甲状腺过氧化物酶。初步尝试以人源甲状腺细胞和甲状旁腺细胞再细胞化支架,重建人源化生物人工内分泌器官并维持关键基因表达,提示脱细胞甲状腺基质可用于功能性生物工程化甲状腺组织开发,有望治疗甲状腺功能减退。

要点

  • 1% SDS灌注可制备保留三维微架构与可灌注血管网的脱细胞甲状腺支架。
  • FRTL-5细胞再细胞化后在体外形成三维滤泡结构并表达甲状腺球蛋白和甲状腺过氧化物酶。
  • 人源甲状腺细胞与甲状旁腺细胞再细胞化可重建人源化生物人工内分泌器官并维持关键基因表达。

核心结论

  • 脱细胞甲状腺细胞外基质支架系统可用于开发功能性生物工程化甲状腺组织,可能用于治疗甲状腺功能减退。

研究设计与样本

  • 基础研究:离体大鼠甲状腺经1%十二烷基硫酸钠灌注制备脱细胞支架,以大鼠甲状腺细胞系经灌注接种再细胞化。
  • 初步研究:脱细胞大鼠甲状腺支架经灌注接种人源甲状腺细胞和甲状旁腺细胞进行再细胞化。

主要发现

  • 脱细胞过程保留复杂三维微架构、可灌注血管网络及天然细胞外基质成分。
  • FRTL-5大鼠甲状腺细胞系再细胞化后可高效重 seeded 甲状腺基质并在体外形成三维滤泡结构。
  • 再细胞化甲状腺显示成功细胞植入及甲状腺特异性功能,包括甲状腺球蛋白和甲状腺过氧化物酶合成。
  • 人源甲状腺细胞和甲状旁腺细胞再细胞化支架后可维持甲状腺球蛋白、甲状腺过氧化物酶和甲状旁腺激素等关键基因表达。

局限性

  • 研究为大鼠模型及体外实验,尚需进一步体内验证。
  • 人源细胞再细胞化仅为初步研究,样本与功能验证有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypothyroidism is a common hormone deficiency condition. Regenerative medicine approaches, such as a bioengineered thyroid, have been proposed as potential therapeutic alternatives for patients with hypothyroidism. This study demonstrates a novel approach to generate thyroid grafts using decellularized rat thyroid matrix. METHODS: Isolated rat thyroid glands were perfused with 1% sodium dodecyl sulfate to generate a decellularized thyroid scaffold. The rat thyroid scaffold was then recellularized with rat thyroid cell line to reconstruct the thyroid by perfusion seeding technique. As a pilot study, the decellularized rat thyroid scaffold was perfused with human-derived thyrocytes and parathyroid cells. RESULTS: The decellularization process retained the intricate three-dimensional microarchitecture with a perfusable vascular network and native extracellular matrix components, allowing efficient reseeding of the thyroid matrix with the FRTL-5 rat thyroid cell line generating three-dimensional follicular structures in vitro. In addition, the recellularized thyroid showed successful cellular engraftment and thyroid-specific function, including synthesis of thyroglobulin and thyroid peroxidase. Moreover, the decellularized rat thyroid scaffold could further be recellularized with human-derived thyroid cells and parathyroid cells to reconstruct a humanized bioartificial endocrine organ, which maintained expression of critical genes such as thyroglobulin, thyroid peroxidase, and parathyroid hormone. CONCLUSION: These findings demonstrate the utility of a decellularized thyroid extracellular matrix scaffold system for the development of functional, bioengineered thyroid tissue, which could potentially be used to treat hypothyroidism.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Pan J, Li H, Fang Y, et al. Regeneration of a Bioengineered Thyroid Using Decellularized Thyroid Matrix. Thyroid. 2018. PMID: 30375266. doi:10.1089/thy.2018.0068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。